Value creation in life sciences – 21: Musings
In this video, we discuss with Guillem, Partner at Ysios Capital about : Tacit knowledge, Scale and how Investors select a biotech/medtech company.
Related Post
In this video, we discuss with Guillem, Partner at Ysios Capital about : Tacit knowledge, Scale and how Investors select a biotech/medtech company.